Mechanisms of Atrial Fibrillation: How Our Knowledge Affects Clinical Practice

Atrial fibrillation (AF) is a very common arrhythmia that mainly affects older individuals. The mechanism of atrial fibrillation is complex and is related to the pathogenesis of trigger activation and the perpetuation of arrhythmia. The pulmonary veins in the left atrium arei confirm that onfirm the most common triggers due to their distinct anatomical and electrophysiological properties. As a result, their electrical isolation by ablation is the cornerstone of invasive AF treatment. Multiple factors and comorbidities affect the atrial tissue and lead to myocardial stretch. Several neurohormonal and structural changes occur, leading to inflammation and oxidative stress and, consequently, a fibrotic substrate created by myofibroblasts, which encourages AF perpetuation. Several mechanisms are implemented into daily clinical practice in both interventions in and the medical treatment of atrial fibrillation.

[1]  M. Ginks,et al.  Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial. , 2023, JAMA.

[2]  S. Crozier,et al.  Supraventricular Arrhythmia Following Patent Foramen Ovale Percutaneous Closure. , 2022, JACC. Cardiovascular interventions.

[3]  D. Tousoulis,et al.  Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics , 2021, International journal of molecular sciences.

[4]  S. Narayan,et al.  Identifying Atrial Fibrillation Mechanisms for Personalized Medicine , 2021, Journal of clinical medicine.

[5]  S. Pocock,et al.  Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction , 2021, Open Heart.

[6]  J. Healey,et al.  Short-term and Long-term Risk of Stroke in Patients With Perioperative Atrial Fibrillation After Cardiac Surgery: Systematic Review and Meta-analysis , 2021, CJC open.

[7]  P. Davlouros,et al.  Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions , 2021, Heart Failure Reviews.

[8]  S. Redline,et al.  Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. , 2021, Circulation.

[9]  E. Kholmovski,et al.  Efficacy of LGE‐MRI‐guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation: The DECAAF II trial: Study design , 2021, Journal of cardiovascular electrophysiology.

[10]  D. Ilatovskaya,et al.  Immune regulation of cardiac fibrosis post myocardial infarction. , 2020, Cellular signalling.

[11]  Feng Liang,et al.  Coronary Heart Disease and Atrial Fibrillation: A Vicious cycle. , 2020, American journal of physiology. Heart and circulatory physiology.

[12]  A. Camm,et al.  Increase in inflammatory T cell subsets in atrial fibrillation: the missing link underlying inflammation in AF , 2020 .

[13]  E. Benjamin,et al.  Epidemiology of Atrial Fibrillation in the 21st Century , 2020, Circulation research.

[14]  R. Wijesurendra,et al.  Mechanisms of atrial fibrillation , 2019, Heart.

[15]  J. Légaré,et al.  Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention , 2019, Front. Immunol..

[16]  S. Nattel,et al.  Postoperative atrial fibrillation: mechanisms, manifestations and management , 2019, Nature Reviews Cardiology.

[17]  Christopher X. Wong,et al.  Electroanatomical Remodeling of the Atria in Obesity: Impact of Adjacent Epicardial Fat. , 2018, JACC. Clinical electrophysiology.

[18]  R. Passman,et al.  Oxidative stress creates a unique, CaMKII-mediated substrate for atrial fibrillation in heart failure. , 2018, JCI insight.

[19]  R. Nagarakanti,et al.  Critical Role of the Posterior Left Atrium in the Perpetuation of Persistent Atrial Fibrillation and the Hybrid Ablation Approach for Persistent Atrial Fibrillation Management: A Single-center Outcomes Study , 2018, The Journal of innovations in cardiac rhythm management.

[20]  Prashanthan Sanders,et al.  Clinical impact of rotor ablation in atrial fibrillation: a systematic review , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[21]  J. Tobis,et al.  Cryptogenic Stroke and Patent Foramen Ovale. , 2018, Journal of the American College of Cardiology.

[22]  Dean P. Jones,et al.  Association between oxidative stress and atrial fibrillation. , 2017, Heart rhythm.

[23]  R. Schuessler,et al.  Postoperative atrial fibrillation following cardiac surgery: a persistent complication , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[24]  Helle K. Iversen,et al.  Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke , 2017, The New England journal of medicine.

[25]  Jean-Marc Schleich,et al.  Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke , 2017, The New England journal of medicine.

[26]  F. Marchlinski,et al.  Techniques for the provocation, localization, and ablation of non-pulmonary vein triggers for atrial fibrillation. , 2017, Heart rhythm.

[27]  Dobromir Dobrev,et al.  Calcium Signaling and Cardiac Arrhythmias. , 2017, Circulation research.

[28]  S. Prabhu,et al.  Alcohol and Atrial Fibrillation: A Sobering Review. , 2016, Journal of the American College of Cardiology.

[29]  U. Schotten,et al.  Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications. , 2016, European heart journal.

[30]  Xianhui Zhou,et al.  [Relationship between new-onset atrial fibrillation and sympathetic neural remodeling in a canine acute myocardial infarction model]. , 2015, Zhonghua xin xue guan bing za zhi.

[31]  G. Angelini,et al.  Inflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery. , 2015, Pharmacology & therapeutics.

[32]  Christopher X. Wong,et al.  Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). , 2015, Journal of the American College of Cardiology.

[33]  P. Ellinor,et al.  Genetics of atrial fibrillation: from families to genomes , 2015, Journal of Human Genetics.

[34]  D. Levy,et al.  Long-Term Outcomes of Secondary Atrial Fibrillation in the Community The Framingham Heart Study , 2015 .

[35]  S. Nattel,et al.  Role of inflammation in atrial fibrillation pathophysiology and management. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[36]  Philip A. Kramer,et al.  Hemoglobin-associated Oxidative Stress in the Pericardial Compartment of Post-operative Cardiac Surgery Patients , 2014, Laboratory Investigation.

[37]  W. Fang,et al.  NKX2-6 mutation predisposes to familial atrial fibrillation. , 2014, International journal of molecular medicine.

[38]  M. Chung,et al.  2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. , 2014, The Journal of thoracic and cardiovascular surgery.

[39]  M. Zoni-Berisso,et al.  Epidemiology of atrial fibrillation: European perspective , 2014, Clinical epidemiology.

[40]  I. Philip,et al.  Perioperative challenges of atrial fibrillation , 2014, Current opinion in anaesthesiology.

[41]  P. Sanders,et al.  Epicardial adipose tissue and atrial fibrillation. , 2014, Cardiovascular research.

[42]  Stanley Nattel,et al.  Role of the Autonomic Nervous System in Atrial Fibrillation: Pathophysiology and Therapy , 2014, Circulation research.

[43]  P. Ellinor,et al.  Emerging Directions in the Genetics of Atrial Fibrillation , 2014, Circulation research.

[44]  Niels Voigt,et al.  Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression , 2014, Circulation research.

[45]  Nazem Akoum,et al.  Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. , 2014, JAMA.

[46]  J. Langberg,et al.  New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry). , 2013, The American journal of cardiology.

[47]  Gemma A. Figtree,et al.  Biological markers of oxidative stress: Applications to cardiovascular research and practice☆ , 2013, Redox biology.

[48]  Deepak Sharma,et al.  The role of Toll-like receptor 2 and hypoxia-induced transcription factor-1α in the atrial structural remodeling of non-valvular atrial fibrillation. , 2013, International journal of cardiology.

[49]  J. Olgin,et al.  Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1. , 2013, Cardiovascular research.

[50]  Jesper Hastrup Svendsen,et al.  J-shaped association between QTc interval duration and the risk of atrial fibrillation: results from the Copenhagen ECG study. , 2013, Journal of the American College of Cardiology.

[51]  W. Fang,et al.  Prevalence and spectrum of Nkx2.5 mutations associated with idiopathic atrial fibrillation , 2013, Clinics.

[52]  D. Dobrev,et al.  The biology of human pulmonary veins: does it help us to better understand AF pathophysiology in patients? , 2013, Heart rhythm.

[53]  U. Schotten,et al.  Transient Receptor Potential Canonical-3 Channel–Dependent Fibroblast Regulation in Atrial Fibrillation , 2012, Circulation.

[54]  Wouter-Jan Rappel,et al.  Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. , 2012, Journal of the American College of Cardiology.

[55]  W. Fang,et al.  Mutational spectrum of the GATA5 gene associated with familial atrial fibrillation. , 2012, International journal of cardiology.

[56]  W. Fang,et al.  Prevalence and spectrum of GATA6 mutations associated with familial atrial fibrillation. , 2012, International journal of cardiology.

[57]  J. S. Janicki,et al.  Tryptase activates isolated adult cardiac fibroblasts via protease activated receptor-2 (PAR-2) , 2012, Journal of Cell Communication and Signaling.

[58]  Stanley Nattel,et al.  Atrial fibrillation pathophysiology: implications for management. , 2011, Circulation.

[59]  W. Fang,et al.  GATA4 loss-of-function mutations in familial atrial fibrillation. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[60]  Leif Hove-Madsen,et al.  PITX2 Insufficiency Leads to Atrial Electrical and Structural Remodeling Linked to Arrhythmogenesis , 2011, Circulation. Cardiovascular genetics.

[61]  X. Jouven,et al.  Atrial Fibrillation and Death After Myocardial Infarction: A Community Study , 2011, Circulation.

[62]  P. Zimetbaum,et al.  Atrial Fibrillation and Atrial Fibrosis , 2010, Journal of cardiovascular pharmacology.

[63]  Ulrich Schotten,et al.  Electropathological Substrate of Long-Standing Persistent Atrial Fibrillation in Patients With Structural Heart Disease: Longitudinal Dissociation , 2010, Circulation. Arrhythmia and electrophysiology.

[64]  Michael J Pencina,et al.  Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. , 2010, JAMA.

[65]  B. Lindsay,et al.  Noninvasive Characterization of Epicardial Activation in Humans With Diverse Atrial Fibrillation Patterns , 2010, Circulation.

[66]  Udo Hoffmann,et al.  Pericardial Fat Is Associated With Prevalent Atrial Fibrillation: The Framingham Heart Study , 2010, Circulation. Arrhythmia and electrophysiology.

[67]  R. Hauer,et al.  The role of connexin40 in atrial fibrillation. , 2009, Cardiovascular research.

[68]  S. Hohnloser,et al.  Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. , 2009, European heart journal.

[69]  Robert Lemery,et al.  Gain-of-function mutation of Nav1.5 in atrial fibrillation enhances cellular excitability and lowers the threshold for action potential firing. , 2009, Biochemical and biophysical research communications.

[70]  A. Russo,et al.  Atrioventricular Nodal Reentrant Tachycardia in Patients Referred for Atrial Fibrillation Ablation: Response to Ablation That Incorporates Slow-Pathway Modification , 2006, Circulation.

[71]  A. Hofman,et al.  Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. , 2006, European heart journal.

[72]  G. Lip,et al.  Atrial fibrillation post-myocardial infarction: Frequency, consequences, and management , 2004, Current heart failure reports.

[73]  R. Villareal,et al.  Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. , 2004, Journal of the American College of Cardiology.

[74]  Liming Zhang,et al.  Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties , 2003, The Journal of physiology.

[75]  Stanley Nattel,et al.  Atrial Electrophysiology and Mechanisms of Atrial Fibrillation , 2003, Journal of cardiovascular pharmacology and therapeutics.

[76]  M. Mansour,et al.  Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. , 2002, Cardiovascular research.

[77]  J. Gore,et al.  Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective. , 2002, American heart journal.

[78]  T. Yau,et al.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[79]  G. Asimakopoulos.  Systemic inflammation and cardiac surgery: an update , 2001, Perfusion.

[80]  J Clémenty,et al.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.

[81]  M. Allessie,et al.  Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. , 1997, Circulation.

[82]  M. Russo,et al.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.

[83]  J S Alpert,et al.  Atrial fibrillation: A review of mechanism, etiology, and therapy , 1997, Clinical cardiology.

[84]  S. Takai,et al.  Chymase is activated in the hamster heart following ventricular fibrosis during the chronic stage of hypertension , 1997, FEBS letters.

[85]  B. Olshansky,et al.  Management of atrial fibrillation after coronary artery bypass graft. , 1996, The American journal of cardiology.

[86]  J A ABILDSKOV,et al.  Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. , 1959, American heart journal.

[87]  David M Herrington,et al.  Atrial fibrillation and the risk of myocardial infarction. , 2015, JAMA internal medicine.

[88]  K. Channon,et al.  Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. , 2008, Journal of the American College of Cardiology.

[89]  K. Weber,et al.  Myocardial fibrosis: role of angiotensin II and aldosterone. , 1993, Basic research in cardiology.